MedicalSystem Biotechnology to Sell 49 PCT Stake in Hong Kong-based Unit for HK$ 90.7 Million Post author:Sam Post published:August 3, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Lysogene Reinforces Its Management Team With The Nomination Of As Chief Operating Officer May 16, 2017 NW Bio Closes 3-Year Convertible Debt Exchange And Financing, And Completes Payoff Of Last $5 Million Of 2014 Bonds June 21, 2017 Bridging Clinical Research & Clinical Health Care: How to Improve Patient Centricity January 8, 2018
Lysogene Reinforces Its Management Team With The Nomination Of As Chief Operating Officer May 16, 2017
NW Bio Closes 3-Year Convertible Debt Exchange And Financing, And Completes Payoff Of Last $5 Million Of 2014 Bonds June 21, 2017